India, Oct. 30 -- The integrated pharmaceutical company RPG Life Sciences has closed its September quarter with strong sales growth and a major push into active ingredients. Behind the headline numbers, a high base, acquisition costs and a new investor in its API arm tell a more layered story about where earnings go next.

The Nifty 50 traded at 23,096, up 0.71%, while the Sensex is up 0.56% to 74,563 on Friday. Following this, the shares of RPG Life Sciences Ltd are trading at Rs. 2,676.90, down 10.88 percent on Friday. The stock touched the intraday high of Rs. 2,849.60 after opening at Rs. 2,812.00 before slipping to a low of Rs. 2,666. The company commands a market capitalization of Rs. 4,427.33 crore

What Happened in the Quarter RP...